Search

everythinglearnresearchcommunity

for

Search:↓

Certain gene variations in the Vitamin D receptor may increase the risk of chronic hair loss.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

TQC shows promise for better hair regrowth in treating hair loss.

Fine wool sheep have more genes for wool quality, while coarse wool sheep have more for skin and muscle traits.

Certain VDR gene changes can affect melanoma risk.

Orobanche rapum extract rejuvenates skin and protects skin bacteria, leading to healthier skin.

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

3,4,5-tri-O-caffeoylquinic acid promotes hair growth by activating the β-catenin pathway.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

A substance called TCQA could potentially darken hair by activating certain genes and increasing melanin.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

CTP-543 is generally safe for treating alopecia areata.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Targeting METTL1 may help slow papillary thyroid cancer growth and spread.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Near-infrared probes can safely and effectively image cysteine protease activity for disease diagnosis.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

Adults with Tatton-Brown-Rahman syndrome may have serious heart problems and need lifelong heart monitoring.

The treatment was not recommended due to limited effectiveness and significant side effects.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.